Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cells
细胞周期可塑性是ER+/HER2-乳腺肿瘤细胞对帕博西尼产生部分耐药性的基础。
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2309261121
Zikry, Tarek M; Wolff, Samuel C; Ranek, Jolene S; Davis, Harris M; Naugle, Ander; Luthra, Namit; Whitman, Austin A; Kedziora, Katarzyna M; Stallaert, Wayne; Kosorok, Michael R; Spanheimer, Philip M; Purvis, Jeremy E